Flagship VentureLabs co-founded ModeRNA Therapeutics with world-leading academic researchers Robert Langer and Kenneth Chien to commercialize a new class of RNA-based drugs.  ModeRNA’s technology platform, invented by Assistant Professor Derrick Rossi of Harvard, also a company co-founder, makes it possible to direct cells to express proteins without changing their genome or creating long term safety concerns.  ModeRNA intends to use its technology to create drugs that target a range of diseases with high unmet need.